Sponsor:
Vanda Pharmaceuticals
Code:
NCT06953869
Conditions
Insomnia Disorder
Eligibility Criteria
Sex: All
Age: 2 - 17
Healthy Volunteers: Not accepted
Interventions
Tasimelteon Oral Suspension
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-21. This information was provided to ClinicalTrials.gov by Vanda Pharmaceuticals on 2026-06-05.